OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the Peripheral Nervous System is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Abstracts	61
	39
	35
	27
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study	24
PNS Abstracts 2023	21
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	20
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	18
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	17
	17
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	17
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	16
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	14
Ofatumumab for treating autoimmune nodopathy	14
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	14
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	13
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	13
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	13
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	13
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	13
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	12
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy	12
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	12
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	11

Issue Information	11
IgM anti‐MAG^± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	10
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	9
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	9
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	9
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	9
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods	9
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	8
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	8
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	8
Techniques for the standard histological and ultrastructural assessment of nerve biopsies	8
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	8
Issue Information	8
Nerve biopsy in acquired neuropathies	8
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	8
	8
Issue Information	8
Issue Information	7
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	7
Issue Information	7
	7
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	6
	6
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy	6
	6
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	6
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response	6
ABSTRACT	6
The autoimmune vulnerability of the node of Ranvier	6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	6
Issue Information	6
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	6
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	6
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	5
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	5
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	5
	5
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes	4
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells	4
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	4
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	4
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	4
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?	4
Anxiety and depression in small fiber neuropathy	4
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	4
2021 Peripheral Nerve Society virtual event	4
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	4
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	3

Issue Information	3
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy	3
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation	3
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	3
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review	3
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children	3
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years	3
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	3
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies	3
Issue Information	3
Issue Information	3
	3
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis	3
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	3
Earlier diagnosis of peripheral neuropathy in primary care: A call to action	3
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	3
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	3
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	3
Issue Information	3
Issue Information	3